Cargando…
Egfl7 promotes tumor escape from immunity
Egfl7 is an endothelial-specific gene which expression is deregulated in human cancers. We showed that Egfl7 promotes tumor escape from immunity by downregulating the expression of leukocyte adhesion molecules in endothelial cells, thus repressing immune cell extravasation into tumors.
Autores principales: | Pinte, Sébastien, Soncin, Fabrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382845/ https://www.ncbi.nlm.nih.gov/pubmed/22737620 http://dx.doi.org/10.4161/onci.18964 |
Ejemplares similares
-
The ART of tumor immune escape
por: Wennerberg, Erik, et al.
Publicado: (2022) -
Antigen shedding into the circulation contributes to tumor immune escape
por: Höchst, Bastian, et al.
Publicado: (2012) -
How the devil facial tumor disease escapes host immune responses
por: Siddle, Hannah V, et al.
Publicado: (2013) -
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
por: Bellone, Matteo, et al.
Publicado: (2013) -
Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells
por: Végran, Frédérique, et al.
Publicado: (2013)